Back to top
more

Labcorp Holdings Inc. (LH)

(Delayed Data from NYSE)

$265.85 USD

265.85
555,186

+5.89 (2.27%)

Updated Aug 8, 2025 04:00 PM ET

After-Market: $266.03 +0.18 (0.07%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value A Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 40% (97 out of 244)

Industry: Medical Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

LabCorp (LH) Introduces Latest Assay for Skin Cancer Patients

by Zacks Equity Research

LabCorp's (LH) new assay is claimed to have shown a demonstrable clinical advantage in patients suffering from melanoma.

Zacks Equity Research

LabCorp (LH) Debuts At-home Collection Kit for Diabetes Testing

by Zacks Equity Research

LabCorp's (LH) at-home collection kit makes it effortless for consumers to understand their diabetes risk and health status using an innovative and approved collection device.

Zacks Equity Research

Here's Why You Should Retain LabCorp (LH) Stock for Now

by Zacks Equity Research

Investors are optimistic about LabCorp's (LH) better-than-expected earnings and robust segmental performance.

Zacks Equity Research

LabCorp (LH) Q1 Earnings Surpass Estimates, Revenues Miss

by Zacks Equity Research

LabCorp (LH) reports better-than-expected earnings for the first quarter, with robust sales within the Drug Development arm driving the top line.

Zacks Equity Research

LabCorp (LH) Surpasses Q1 Earnings Estimates

by Zacks Equity Research

LabCorp (LH) delivered earnings and revenue surprises of 3.91% and 3.49%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Urmimala Biswas headshot

Medical Products Stocks' Earnings on Apr 28: TMO, BIO & More

by Urmimala Biswas

Medical Products companies' results are likely to reflect a rebound in the base business. Let's see how TMO, BIO, LH and RMD fare this time.

Zacks Equity Research

LabCorp (LH) to Report Q1 Earnings: What's in the Cards?

by Zacks Equity Research

Robust base business growth and notable launches are likely to have contributed to LabCorp's (LH) Q1 performance.

Zacks Equity Research

LabCorp (LH) Stock Moves -0.57%: What You Should Know

by Zacks Equity Research

LabCorp (LH) closed the most recent trading day at $276.30, moving -0.57% from the previous trading session.

Zacks Equity Research

Analysts Estimate LabCorp (LH) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

LabCorp (LH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

LabCorp (LH) Gains But Lags Market: What You Should Know

by Zacks Equity Research

LabCorp (LH) closed at $271.14 in the latest trading session, marking a +1.5% move from the prior day.

Zacks Equity Research

LabCorp (LH) Gains As Market Dips: What You Should Know

by Zacks Equity Research

LabCorp (LH) closed the most recent trading day at $264.88, moving +0.24% from the previous trading session.

Zacks Equity Research

LabCorp (LH) Dips More Than Broader Markets: What You Should Know

by Zacks Equity Research

LabCorp (LH) closed the most recent trading day at $263.66, moving -1.99% from the previous trading session.

Zacks Equity Research

LabCorp (LH) Gains From Covance Arm Growth, Cost Pressure Ails

by Zacks Equity Research

LabCorp's (LH) Covance Drug Development arm is benefiting from its collaborations with leading pharmaceutical and biotechnology companies.

Zacks Equity Research

LabCorp (LH) Outpaces Stock Market Gains: What You Should Know

by Zacks Equity Research

LabCorp (LH) closed the most recent trading day at $273.96, moving +0.93% from the previous trading session.

Zacks Equity Research

LabCorp (LH) Stock Sinks As Market Gains: What You Should Know

by Zacks Equity Research

In the latest trading session, LabCorp (LH) closed at $271.44, marking a -0.09% move from the previous day.

Zacks Equity Research

Should Value Investors Consider LabCorp (LH) Stock Now?

by Zacks Equity Research

Let's see if LabCorp (LH) stock is a good choice for value-oriented investors right now from multiple angles.

Zacks Equity Research

LabCorp (LH) Gains But Lags Market: What You Should Know

by Zacks Equity Research

In the latest trading session, LabCorp (LH) closed at $274.33, marking a +0.11% move from the previous day.

Zacks Equity Research

LabCorp (LH) Stock Moves -0.27%: What You Should Know

by Zacks Equity Research

LabCorp (LH) closed at $265.49 in the latest trading session, marking a -0.27% move from the prior day.

Zacks Equity Research

Here's Why You Should Hold on to LabCorp (LH) Stock For Now

by Zacks Equity Research

Investors are optimistic about LabCorp's (LH) better-than-expected results and robust base business performance.

Zacks Equity Research

Walgreens (WBA) Expands Access to COVID-19 Test With LabCorp

by Zacks Equity Research

Walgreens (WBA) will enable more communities to access reliable, convenient testing services as and when required with the addition of Pixel by LabCorp COVID-19 at-home collection kit.

Zacks Equity Research

Is John Hancock Multifactor Mid Cap ETF (JHMM) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for JHMM

Zacks Equity Research

Should John Hancock Multifactor Mid Cap ETF (JHMM) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for JHMM

Zacks Equity Research

LabCorp (LH) Expands Clinical Laboratory Services With New Pact

by Zacks Equity Research

LabCorp's (LH) recent collaboration will enable it to administer Ascension's hospital-based laboratories in 10 states and purchase select assets of the health system's outreach laboratory business.

Zacks Equity Research

LabCorp (LH) Q4 Earnings Surpass Estimates, Margins Down

by Zacks Equity Research

LabCorp (LH) reports better-than-expected results for the fourth quarter, with solid contributions from the Drug Development business driving the top line.

Zacks Equity Research

LabCorp (LH) Q4 Earnings and Revenues Beat Estimates

by Zacks Equity Research

LabCorp (LH) delivered earnings and revenue surprises of 14.75% and 2.95%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?